- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about KTTA
Recent news which mentions KTTA
What's Happening With Pasithea Therapeutics Stock Today?
July 20, 2023
From Benzinga
From Benzinga
From Benzinga
Why Theriva Biologics Are Trading Higher By Over 76%; Here Are 20 Stocks Moving Premarket
June 28, 2023
From Benzinga
Why THOR Industries Shares Are Trading Higher By 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
June 06, 2023
From Benzinga
Why Bluejay Diagnostics Shares Are Trading Lower By 12%; Here Are 20 Stocks Moving Premarket
June 06, 2023
From Benzinga
From InvestorPlace
Lucy Scientific Goes After Pasithea Therapeutics Common Shares For A '142% Premium' Deal
June 05, 2023
From Benzinga
Disney, Amgen, First Republic, Psychedelics: How One CEO's Universal Deal-Making Approach Shapes Industries
June 05, 2023
From Benzinga
Why Pasithea Therapeutics Stock Is Up Today
June 05, 2023
From Benzinga
From Benzinga
Why Amedisys Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
June 05, 2023
From Benzinga
From Benzinga
Stocks That Hit 52-Week Lows On Monday
March 27, 2023
From Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
December 28, 2022
From Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
December 22, 2022
From Benzinga
From Benzinga
Pasithea' Largest Investor Group Says AlloMek Therapeutics Deal Ill-timed, Highly Dilutive
October 14, 2022
Tickers
KTTA
From Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
October 12, 2022
From Benzinga
EXCLUSIVE: Pasithea Bolsters CNS-Focused Pipeline With AlloMek Therapeutics Acquisition
October 12, 2022
Tickers
KTTA
From Benzinga
New Drugs And Therapies Are Giving MS And ALS Sufferers New Hope
October 10, 2022
From Benzinga
Biotech Company Pleased With Results Of Early Testing Demonstrating Vaccine Potential For Multiple Sclerosis
October 03, 2022
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
August 31, 2022
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
August 30, 2022
From Benzinga
EXCLUSIVE: Pasithea's Multiple Sclerosis Vaccine Candidate Shows Efficacy In Animal Studies, With Potential In Monkeypox
August 11, 2022
Tickers
KTTA
From Benzinga
Smaller Biotechs May Pave Way For New Generation Of Therapeutics For Hard-to-Treat Neurological Disorders
August 08, 2022
From Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
August 02, 2022
From Benzinga
A Monoclonal Antibody Treatment For ALS Could Begin Human Trials By 2023, According To Pasithea
July 28, 2022
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.